Powell, J. D. et al. 1991 Ann. N.Y. Acad. Sci. USA vol. 636 pp. 360-363. |
Powell, J. D. et al. 1993 Chem. Exp. Immunol. vol. 91 pp. 473-481. |
Markovicz, C. et al. 1992 AIDWS Res. Human Retrovir vol. 8 pp. 1039-1050. |
Stein, D.S. et al. 1993. Chemical Infection Diseases vol. 17 pp. 749-771. |
Carson, K.L., 1994, Genetic Engineering News vol. 14 No. 9 pp. 1,24,34. |
Powell, J.D. et al. 1990, Sym. Nonhum. Private Models AIDS v. 8 p. 43. |
Markewicz, C et al, 1991, Int. Conf. AIDS vol. 7 No. 2 p. 74. |
Copeland et al, "CD8 T Lymphocytes-Mediated Suppression of HIV-1 LTR-Mediated Transcription Shows No Correlation With Clinical Stage Of Disease or Health Status," Eleventh Int'l Conference on AIDS, Vancouver, Jul. 7-12, 1996, p. 227, Abstract No. Tu.A.395. |
Barker et al., "Effects of TH1 and TH2 Cytokines On CN8.sup.+ Cell Response Against Human Immunodeficiency Virus Implication For Long-Term Survival," Proc. Natl. Acad. Sci. USA 92:11135-11139, Nov. 1995. |
Kinter et al., "Interlinkin 2 Induces CD8.sup.+ TCell-Mediated Suppression of Human Immunodeficiency Virus Replication in CD4.sup.+ T Cells And This Effect Overrides Its Ability To Stimulate Virus Expression," Proc. Nat'l.Acad.Sci USA 92:10985-10989, Nov. 1995. |
Fahey et al., "Status of Immune Based Therapies In HIV Infection and AIDS," Clin. Exp. Immunol. 88:1-5, Apr. 1997. |
Fox, J.L., "No Winners Against AIDS," Bio/Technology 12:128, Feb. 1994. |
Barre-Sinoussi, F. et al., 1983; Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS). Science 220:868-871. |
Gallo, R. et al., 1984, Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS. Science 224:500-503. |
Wong-Staal, F. and Gallo, R., 1985; Human T-Lymphotrophic Retroviruses. Nature 317:395-403. |
Walker et al., 1986; CD8.sup.+ Lymphocytes Can Control HIV Infection in Vitro by Supressing Virus Replication. Science 234:1563-1566. |
Kannagi, M. et al., 1988; Suppression of Simian Immunodeficiency Virus Replication in Vitro By CD8.sup.+ Lymphocytes. Journal of Immunology 140(7): 2237-2242. |
Tsubota, H. et al., 1989; A Cytotoxic T Lymphocye Inhibits Acquired Immunodeficiency Syndrome Virus Replication in Peripheral Blood Lymphocytes. J. Exp. Med. 169:1421-1434. |
Walker, C. and Levy, J., 1989; A Diffusable Lymphokine Produced by CD8.sup.+ T Lymphocytes Suppresses HIV Replication. Immunology 66:628-630. |
Tsubota, H. et al., 1989; CD8.sup.+ CD4.sup.- Lymphocyte Lines Can Harbor the AIDS Virus In Vitro. Journal of Immunology 143(3):858-863. |
Cullen, B. and Greene, W., 1989, 1989; Regulatory Pathways Governing HIV Replication. Cell 58:423-426. |
Walker, C. et al. 1989; CD8.sup.+ T Lymphocyte Control of HIV Replication in Cultured CD4.sup.+ Cells Varies among Infected Individuals. Cellular Immunology 119:470-475. |
Brinchmann, J. et al., 1989; Reliable Isolation of Human Immunodeficiency Virus from Cultures of Naturally Infected CD4.sup.+ T Cells. Journal of Virological Methods 25:293-300. |
Brinchmann, J. et al., 1990; CD8.sup.+ T Cells Inhibit HIV Replication in Naturally Infected CD4.sup.+ T Cells, Evidence for a Soluble Inhibitor. J. Immunol. 144:2961-2966. |
Kannagi, M. et al., 1990; Interference with Human Immunodeficiency Virus (HIV) Replication by CD8.sup.+ T Cells in Peripheral Blood Leukocytes of Asymptomatic HIV Carriers In Vitro. Journal of Virology 64(7):3399-3406. |
Wivott, L. et al., 1990; CD8.sup.+ Lymphocytes Suppress HIV Production by Autologous CD4.sup.+ Cells without Eliminating the Infected from Culture. Cellular Immunology 128:628-634. |
Castro, B., 1991; Suppression of Human Immunodeficiency Virus Replication by CD8.sup.+ Cells from Infected and Uninfected Chimpanzees. Cellular Immunology 132:246-255. |
Mackewicz, C., et al., 1991; CD*.sup.+ Cell Anti-HIV Activity Correlates with the Clinical State of the Infected Individual. J. Clin. Invest. 87:1462-1466. |
Brinchmann, J. et al., 1991; In Vitro Replication of HIV-1 in Naturally Infected CD4.sup.+ T Cells is Inhibited by rIFN.alpha..sub.2 and by a Soluble Factor Secreted by Activated CD8.sup.+ T Cells, But Not By rIFN.sub..beta., rIFN.varies., or Recombinant Tumor Necrosis Factor-.alpha.. Journal of Acquired Immune Deficiency Syndrome 4(5):480-488. |
Walker, C. et al., 1991; CD8.sup.8 Cells from HIV-1-Infected Individuals Inhibit Acute Infection by Human and Primate Immunodeficiency Viruses. Cellular Immunology 137:420-428. |
Walker, C. et al., 1991; Inhibition of Human Immunodeficiency Virus Replication in Acutely Infected CD$.sup.+ Cells by CD8.sup.+ Cells Involves a Noncytotoxic Mechanism. J. Virology 65(11):5921-5927. |
Powell, J. et al., 1990; Sym. Nonhuman Primate Models AIDS 8:43. |
Mackewicz, C. et al., 1991; CD8.sup.+ Lymphocytes from HIV-1 Seropositive Individuals Block HIV Replication in CD4.sup.+ Lymphocytes by Inhibiting Viral RNA Synthesis. Int. Conf. AIDS 7: 74. |
Powell, J. et al., 1991; Regulatioin of Immune Activation/Retroviral Replication by CD8.sup.+ T Cells. Ann. N.Y. Acad. Sci. USA 636:360-363. |
Mackewicz, C. et al., 1992; CD8.sup.+ Cell Anti-HIV Activity: Non-Lytic Suppression of Virus Replication. AIDS Res. Human Retroviruses 8:1039-1050. |
Powell, J. et al., 1993; Inhibition of Cellular Activation of Retroviral Replication by CD8.sup.+ T Cells Derived from Non-Human Primates. Clin. Exp. Immunol. 91:473-481. |
Stein, D. et al., 1993; Immune-Based Therapeutics: Scientific Rationale and the Promising Approaches to the Treatment of the Human Immunodeficiency Virus-Infected Individual. Clin. Infct. Dis. 17:749-771. |
Carson, K. et al., 1994; Companies Remain Hopeful for Vaccines for AIDS Despite Discouraging Results. Gen. Engineering News 14:1,24,34. |
Copeland, K. et al., 1996; CD8.sup.+ Lymphocyte-Mediated Suppression of HIV-1 LTR-Mediated Transcription Shows No Correlation with Clinical Stage of Disease or Health Status. XIth Int'l Con. AIDS, Vancouver, Jul. 7-12:12 (Abs. Tu,A,395). |
Fahey, J. and Schooley, R. et al., 1992; Status of Immune-Based Therapies in HIV Infection and AIDS. Clin. Exp. Immunol. 88:1-5. |
Fox, J., 1994, No Winners Against AIDS. Bio/Technology 12:128. |
Barker, E. et al., 1995; Effects of T.sub.H 1 and T.sub.H 2 Cytokines on CD8.sup.+ Cell response Against Human Immunodeficiency Virus: Implications for Long-Term Survival. Proc. Natl. Acad. Sci. USA 92:11135-11139. |
Kinter, A. et al., 1995; Interleukin 2 Induces CD8.sup.+ T Cell-Mediated Suppression of Human Immunodeficiency Virus Replication in CD4.sup.+ T Cells and this Effect Overrides its Ability to Stimulate Virus Expression. Proc. Natl. Acad. Sci. USA 92A:10985-10989. |
Burgess, R., 1987; Protein Purication, Micro to Macro. ALan R. Liss, New York. pp. 17-26. |
Old, R., et al., 1989; Principles of Gene Manipulation, an Introduction to Genetic Engineering. Blackwell Scientific Publications, Oxford. pp. 137-139. |
Anderson et al., 1990; A Monoclonal Antibody Reactive with a 15-kDa Cytoplasmic Granule-Associated Protein Defines Subpopulation of CD8.sup.+ T Lymphocytes. J. Immunol. 144:574-582. |
Pantaleo et al., 1992; Defective Clonogenic Potential of CD8.sup.+ T Lymphocytes in Patients with AIDS. Expansion In Vivo Nonclonogenic CD3.sup.+ CD8.sup.+ DR.sup.+ CD25-T Cell Population. J. Immunol. 144:1702. |
Chen et al., 1993; CD8.sup.+ T Lymphocyte-Mediated Inhibition of HIV-1 Long Terminal Repeat Transcription: a Novel Antiviral Mechanism. AIDS Res. Hum. Retroviruses 9:1079-1086. |
Lacey et al. "Herpesvirus saimiri Transformation of Suppressive CD8.sup.+ T Lymphocytes From A HIV.sup.+ Asymptomatic Patient," AIDS Res. Human Retroviruses, vol. 10, Supplement, p. 570, Abstract No. 29, Sep. 1994. |